From OpenAI’s offices to a deal with Eli Lilly — how Chai Discovery became one of the flashiest names in AI drug developmentAI, biotech, Biotech & Health, Chai Discovery, Eli Lilly, General Catalyst, OpenAI, sam altman The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley’s most influential VCs.
The race to regulate AI has sparked a federal vs state showdown AI, AI moratorium, AI policy, Government & Policy, leading the future, ndaa, technology
